메뉴 건너뛰기




Volumn 32, Issue 18, 2014, Pages 2100-2108

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines

Author keywords

MERS CoV; Mucosal immune response; Neutralizing antibody; Receptor binding domain; Spike protein; Systemic immune response

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; MONTANIDE ISA 51; NEUTRALIZING ANTIBODY; RECOMBINANT MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS RECEPTOR BINDING DOMAIN FC PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT RECEPTOR; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG;

EID: 84896545485     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.004     Document Type: Article
Times cited : (127)

References (44)
  • 2
    • 84883105254 scopus 로고    scopus 로고
    • Middle East respiratory syndrome coronavirus infections in health care workers
    • Memish Z.A., Zumla A.I., Assiri A. Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med 2013, 369:884-886.
    • (2013) N Engl J Med , vol.369 , pp. 884-886
    • Memish, Z.A.1    Zumla, A.I.2    Assiri, A.3
  • 4
    • 0344395657 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
    • Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426:450-454.
    • (2003) Nature , vol.426 , pp. 450-454
    • Li, W.1    Moore, M.J.2    Vasilieva, N.3    Sui, J.4    Wong, S.K.5    Berne, M.A.6
  • 5
    • 84874996988 scopus 로고    scopus 로고
    • Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
    • Raj V.S., Mou H., Smits S.L., Dekkers D.H., Muller M.A., Dijkman R., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013, 495:251-254.
    • (2013) Nature , vol.495 , pp. 251-254
    • Raj, V.S.1    Mou, H.2    Smits, S.L.3    Dekkers, D.H.4    Muller, M.A.5    Dijkman, R.6
  • 6
    • 84877339392 scopus 로고    scopus 로고
    • The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies
    • Gierer S., Bertram S., Kaup F., Wrensch F., Heurich A., Kramer-Kuhl A., et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 2013, 87:5502-5511.
    • (2013) J Virol , vol.87 , pp. 5502-5511
    • Gierer, S.1    Bertram, S.2    Kaup, F.3    Wrensch, F.4    Heurich, A.5    Kramer-Kuhl, A.6
  • 7
    • 84872146295 scopus 로고    scopus 로고
    • Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines
    • Muller M.A., Raj V.S., Muth D., Meyer B., Kallies S., Smits S.L., et al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio 2012, 3.
    • (2012) MBio , pp. 3
    • Muller, M.A.1    Raj, V.S.2    Muth, D.3    Meyer, B.4    Kallies, S.5    Smits, S.L.6
  • 8
    • 84877262971 scopus 로고    scopus 로고
    • Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation
    • Chan J.F., Chan K.H., Choi G.K., To K.K., Tse H., Cai J.P., et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 2013, 207:1743-1752.
    • (2013) J Infect Dis , vol.207 , pp. 1743-1752
    • Chan, J.F.1    Chan, K.H.2    Choi, G.K.3    To, K.K.4    Tse, H.5    Cai, J.P.6
  • 9
    • 35548966062 scopus 로고    scopus 로고
    • Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
    • Bai B., Lu X., Meng J., Hu Q., Mao P., Lu B., et al. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. Mol Immunol 2008, 45:868-875.
    • (2008) Mol Immunol , vol.45 , pp. 868-875
    • Bai, B.1    Lu, X.2    Meng, J.3    Hu, Q.4    Mao, P.5    Lu, B.6
  • 10
    • 70349383960 scopus 로고    scopus 로고
    • Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
    • Du L., Zhao G., Chan C.C., Sun S., Chen M., Liu Z., et al. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Virology 2009, 393:144-150.
    • (2009) Virology , vol.393 , pp. 144-150
    • Du, L.1    Zhao, G.2    Chan, C.C.3    Sun, S.4    Chen, M.5    Liu, Z.6
  • 11
    • 17044375920 scopus 로고    scopus 로고
    • Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies
    • He Y., Lu H., Siddiqui P., Zhou Y., Jiang S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol 2005, 174:4908-4915.
    • (2005) J Immunol , vol.174 , pp. 4908-4915
    • He, Y.1    Lu, H.2    Siddiqui, P.3    Zhou, Y.4    Jiang, S.5
  • 12
    • 40449085104 scopus 로고    scopus 로고
    • Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
    • Du L., Zhao G., Lin Y., Sui H., Chan C., Ma S., et al. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol 2008, 180:948-956.
    • (2008) J Immunol , vol.180 , pp. 948-956
    • Du, L.1    Zhao, G.2    Lin, Y.3    Sui, H.4    Chan, C.5    Ma, S.6
  • 13
    • 33645796224 scopus 로고    scopus 로고
    • Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice
    • Lee J.S., Poo H., Han D.P., Hong S.P., Kim K., Cho M.W., et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 2006, 80:4079-4087.
    • (2006) J Virol , vol.80 , pp. 4079-4087
    • Lee, J.S.1    Poo, H.2    Han, D.P.3    Hong, S.P.4    Kim, K.5    Cho, M.W.6
  • 14
    • 60749134643 scopus 로고    scopus 로고
    • The spike protein of SARS-CoV - a target for vaccine and therapeutic development
    • Du L., He Y., Zhou Y., Liu S., Zheng B.J., Jiang S. The spike protein of SARS-CoV - a target for vaccine and therapeutic development. Nat Rev Microbiol 2009, 7:226-236.
    • (2009) Nat Rev Microbiol , vol.7 , pp. 226-236
    • Du, L.1    He, Y.2    Zhou, Y.3    Liu, S.4    Zheng, B.J.5    Jiang, S.6
  • 15
    • 84886007720 scopus 로고    scopus 로고
    • Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus
    • Chen Y., Rajashankar K.R., Yang Y., Agnihothram S.S., Liu C., Lin Y.L., et al. Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J Virol 2013, 87:10777-10783.
    • (2013) J Virol , vol.87 , pp. 10777-10783
    • Chen, Y.1    Rajashankar, K.R.2    Yang, Y.3    Agnihothram, S.S.4    Liu, C.5    Lin, Y.L.6
  • 16
    • 84881232247 scopus 로고    scopus 로고
    • The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies
    • Mou H., Raj V.S., van Kuppeveld F.J., Rottier P.J., Haagmans B.L., Bosch B.J. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol 2013, 87:9379-9383.
    • (2013) J Virol , vol.87 , pp. 9379-9383
    • Mou, H.1    Raj, V.S.2    van Kuppeveld, F.J.3    Rottier, P.J.4    Haagmans, B.L.5    Bosch, B.J.6
  • 17
    • 84881190964 scopus 로고    scopus 로고
    • Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
    • Wang N., Shi X., Jiang L., Zhang S., Wang D., Tong P., et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 2013, 23:986-993.
    • (2013) Cell Res , vol.23 , pp. 986-993
    • Wang, N.1    Shi, X.2    Jiang, L.3    Zhang, S.4    Wang, D.5    Tong, P.6
  • 18
    • 84886875619 scopus 로고    scopus 로고
    • Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development
    • Du L., Zhao G., Kou Z., Ma C., Sun S., Poon V.K., et al. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol 2013, 87:9939-9942.
    • (2013) J Virol , vol.87 , pp. 9939-9942
    • Du, L.1    Zhao, G.2    Kou, Z.3    Ma, C.4    Sun, S.5    Poon, V.K.6
  • 19
    • 84880641719 scopus 로고    scopus 로고
    • A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses
    • Li Y., Du L., Qiu H., Zhao G., Wang L., Zhou Y., et al. A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses. Biosci Trends 2013, 7:129-137.
    • (2013) Biosci Trends , vol.7 , pp. 129-137
    • Li, Y.1    Du, L.2    Qiu, H.3    Zhao, G.4    Wang, L.5    Zhou, Y.6
  • 20
    • 33947189535 scopus 로고    scopus 로고
    • Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
    • Du L., Zhao G., He Y., Guo Y., Zheng B.J., Jiang S., et al. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine 2007, 25:2832-2838.
    • (2007) Vaccine , vol.25 , pp. 2832-2838
    • Du, L.1    Zhao, G.2    He, Y.3    Guo, Y.4    Zheng, B.J.5    Jiang, S.6
  • 21
    • 5144234050 scopus 로고    scopus 로고
    • Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
    • He Y., Zhou Y., Liu S., Kou Z., Li W., Farzan M., et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun 2004, 324:773-781.
    • (2004) Biochem Biophys Res Commun , vol.324 , pp. 773-781
    • He, Y.1    Zhou, Y.2    Liu, S.3    Kou, Z.4    Li, W.5    Farzan, M.6
  • 22
    • 84872190107 scopus 로고    scopus 로고
    • A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection
    • Du L., Zhao G., Sun S., Zhang X., Zhou X., Guo Y., et al. A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PLoS ONE 2013, 8:e53568.
    • (2013) PLoS ONE , vol.8
    • Du, L.1    Zhao, G.2    Sun, S.3    Zhang, X.4    Zhou, X.5    Guo, Y.6
  • 23
    • 67651204591 scopus 로고    scopus 로고
    • Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors
    • Martyn J.C., Cardin A.J., Wines B.D., Cendron A., Li S., Mackenzie J., et al. Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors. Arch Virol 2009, 154:1129-1138.
    • (2009) Arch Virol , vol.154 , pp. 1129-1138
    • Martyn, J.C.1    Cardin, A.J.2    Wines, B.D.3    Cendron, A.4    Li, S.5    Mackenzie, J.6
  • 24
    • 34250614327 scopus 로고    scopus 로고
    • Immunogenicity of the outer domain of a HIV-1 clade C gp120
    • Chen H., Xu X., Jones I.M. Immunogenicity of the outer domain of a HIV-1 clade C gp120. Retrovirology 2007, 4:33.
    • (2007) Retrovirology , vol.4 , pp. 33
    • Chen, H.1    Xu, X.2    Jones, I.M.3
  • 25
    • 84891885053 scopus 로고    scopus 로고
    • A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines
    • Du L., Kou Z., Ma C., Tao X., Wang L., Zhao G., et al. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLoS ONE 2013, 8:e81587.
    • (2013) PLoS ONE , vol.8
    • Du, L.1    Kou, Z.2    Ma, C.3    Tao, X.4    Wang, L.5    Zhao, G.6
  • 26
    • 40249111494 scopus 로고    scopus 로고
    • Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
    • Du L., Zhao G., Lin Y., Chan C., He Y., Jiang S., et al. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine 2008, 26:1644-1651.
    • (2008) Vaccine , vol.26 , pp. 1644-1651
    • Du, L.1    Zhao, G.2    Lin, Y.3    Chan, C.4    He, Y.5    Jiang, S.6
  • 27
    • 84883262923 scopus 로고    scopus 로고
    • Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells
    • Tao X., Hill T.E., Morimoto C., Peters C.J., Ksiazek T.G., Tseng C.T. Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells. J Virol 2013, 87:9953-9958.
    • (2013) J Virol , vol.87 , pp. 9953-9958
    • Tao, X.1    Hill, T.E.2    Morimoto, C.3    Peters, C.J.4    Ksiazek, T.G.5    Tseng, C.T.6
  • 28
    • 84879041188 scopus 로고    scopus 로고
    • Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart
    • Cauchemez S., Van K.M., Riley S., Donnelly C., Fraser C., Ferguson N. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill 2013, 18.
    • (2013) Euro Surveill , pp. 18
    • Cauchemez, S.1    Van, K.M.2    Riley, S.3    Donnelly, C.4    Fraser, C.5    Ferguson, N.6
  • 29
    • 84882918127 scopus 로고    scopus 로고
    • Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
    • Breban R., Riou J., Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013, 382:694-699.
    • (2013) Lancet , vol.382 , pp. 694-699
    • Breban, R.1    Riou, J.2    Fontanet, A.3
  • 30
    • 84887148359 scopus 로고    scopus 로고
    • Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate
    • Almazan F., DeDiego M.L., Sola I., Zuniga S., Nieto-Torres J.L., Marquez-Jurado S., et al. Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio 2013, 4:e00650-e713.
    • (2013) MBio , vol.4
    • Almazan, F.1    DeDiego, M.L.2    Sola, I.3    Zuniga, S.4    Nieto-Torres, J.L.5    Marquez-Jurado, S.6
  • 31
    • 65649110128 scopus 로고    scopus 로고
    • Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
    • Du L., Zhao G., Li L., He Y., Zhou Y., Zheng B.J., et al. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochem Biophys Res Commun 2009, 384:486-490.
    • (2009) Biochem Biophys Res Commun , vol.384 , pp. 486-490
    • Du, L.1    Zhao, G.2    Li, L.3    He, Y.4    Zhou, Y.5    Zheng, B.J.6
  • 32
    • 84869081784 scopus 로고    scopus 로고
    • Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?
    • Chan J.F., Li K.S., To K.K., Cheng V.C., Chen H., Yuen K.Y. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?. J Infect 2012, 65:477-489.
    • (2012) J Infect , vol.65 , pp. 477-489
    • Chan, J.F.1    Li, K.S.2    To, K.K.3    Cheng, V.C.4    Chen, H.5    Yuen, K.Y.6
  • 33
    • 84881553690 scopus 로고    scopus 로고
    • Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans
    • e00473-12
    • van B.S., de G.M., Lauber C., Bestebroer T.M., Raj V.S., Zaki A.M., et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 2012, 3:e00473-12.
    • (2012) MBio , vol.3
    • van, B.S.1    de, G.M.2    Lauber, C.3    Bestebroer, T.M.4    Raj, V.S.5    Zaki, A.M.6
  • 34
    • 84886937421 scopus 로고    scopus 로고
    • Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus ankara efficiently induces virus-neutralizing antibodies
    • Song F., Fux R., Provacia L.B., Volz A., Eickmann M., Becker S., et al. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus ankara efficiently induces virus-neutralizing antibodies. J Virol 2013, 87:11950-11954.
    • (2013) J Virol , vol.87 , pp. 11950-11954
    • Song, F.1    Fux, R.2    Provacia, L.B.3    Volz, A.4    Eickmann, M.5    Becker, S.6
  • 35
    • 13944257660 scopus 로고    scopus 로고
    • Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection
    • Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., et al. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J Virol 2005, 79:2910-2919.
    • (2005) J Virol , vol.79 , pp. 2910-2919
    • Ichinohe, T.1    Watanabe, I.2    Ito, S.3    Fujii, H.4    Moriyama, M.5    Tamura, S.6
  • 36
    • 35148824709 scopus 로고    scopus 로고
    • Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge
    • Ichinohe T., Kawaguchi A., Tamura S., Takahashi H., Sawa H., Ninomiya A., et al. Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Microbes Infect 2007, 9:1333-1340.
    • (2007) Microbes Infect , vol.9 , pp. 1333-1340
    • Ichinohe, T.1    Kawaguchi, A.2    Tamura, S.3    Takahashi, H.4    Sawa, H.5    Ninomiya, A.6
  • 37
    • 84876698358 scopus 로고    scopus 로고
    • Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season
    • Frasca D., Diaz A., Romero M., Mendez N.V., Landin A.M., Blomberg B.B. Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season. Immun Ageing 2013, 10:14.
    • (2013) Immun Ageing , vol.10 , pp. 14
    • Frasca, D.1    Diaz, A.2    Romero, M.3    Mendez, N.V.4    Landin, A.M.5    Blomberg, B.B.6
  • 38
    • 84880053841 scopus 로고    scopus 로고
    • Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
    • Guery B., Poissy J., El M.L., Sejourne C., Ettahar N., Lemaire X., et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 2013, 381:2265-2272.
    • (2013) Lancet , vol.381 , pp. 2265-2272
    • Guery, B.1    Poissy, J.2    El, M.L.3    Sejourne, C.4    Ettahar, N.5    Lemaire, X.6
  • 39
    • 84882614929 scopus 로고    scopus 로고
    • Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
    • Drosten C., Seilmaier M., Corman V.M., Hartmann W., Scheible G., Sack S., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013, 13:745-751.
    • (2013) Lancet Infect Dis , vol.13 , pp. 745-751
    • Drosten, C.1    Seilmaier, M.2    Corman, V.M.3    Hartmann, W.4    Scheible, G.5    Sack, S.6
  • 40
    • 77956478136 scopus 로고    scopus 로고
    • CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein
    • Zhao K., Yang B., Xu Y., Wu C. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein. Vaccine 2010, 28:6666-6674.
    • (2010) Vaccine , vol.28 , pp. 6666-6674
    • Zhao, K.1    Yang, B.2    Xu, Y.3    Wu, C.4
  • 41
    • 67651235728 scopus 로고    scopus 로고
    • Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection
    • Fan Y.Y., Huang Z.T., Li L., Wu M.H., Yu T., Koup R.A., et al. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Arch Virol 2009, 154:1093-1099.
    • (2009) Arch Virol , vol.154 , pp. 1093-1099
    • Fan, Y.Y.1    Huang, Z.T.2    Li, L.3    Wu, M.H.4    Yu, T.5    Koup, R.A.6
  • 42
    • 33646894897 scopus 로고    scopus 로고
    • Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses
    • Huang J., Ma R., Wu C.Y. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine 2006, 24:4905-4913.
    • (2006) Vaccine , vol.24 , pp. 4905-4913
    • Huang, J.1    Ma, R.2    Wu, C.Y.3
  • 43
    • 84855170210 scopus 로고    scopus 로고
    • A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
    • Kakimi K., Isobe M., Uenaka A., Wada H., Sato E., Doki Y., et al. A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. Int J Cancer 2011, 129:2836-2846.
    • (2011) Int J Cancer , vol.129 , pp. 2836-2846
    • Kakimi, K.1    Isobe, M.2    Uenaka, A.3    Wada, H.4    Sato, E.5    Doki, Y.6
  • 44
    • 84866547636 scopus 로고    scopus 로고
    • Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor
    • Do Y., Didierlaurent A.M., Ryu S., Koh H., Park C.G., Park S., et al. Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor. Vaccine 2012, 30:6359-6367.
    • (2012) Vaccine , vol.30 , pp. 6359-6367
    • Do, Y.1    Didierlaurent, A.M.2    Ryu, S.3    Koh, H.4    Park, C.G.5    Park, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.